Trial intelligence / Profile preview

Pregabalin for Sleep Maintenance in Fibromyalgia

NCT00883740Phase 3Completed

Sponsor
Viatris
Start
Jun 2009
Primary completion
Jun 2010
Modality
Small Molecules
Countries
3
01

Overview

Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Lyrica with Placebo (2 arms). Primary endpoint: Wake After Sleep Onset at Week 11. Started Jun 2009; status: completed.

02

Drugs

pregabalin
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT00883740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00883740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call